Advertisement
Grab your lab coat. Let's get started
Welcome!
Welcome!
Create an account below to get 6 C&EN articles per month, receive newsletters and more - all free.
It seems this is your first time logging in online. Please enter the following information to continue.
As an ACS member you automatically get access to this site. All we need is few more details to create your reading experience.
Not you? Sign in with a different account.
Not you? Sign in with a different account.
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Business
Celera gets bird flu grant
August 28, 2006
| A version of this story appeared in
Volume 84, Issue 35
Celera Genomics has received a $900,000 grant from NIH to support a three-year project to develop and commercialize an avian flu diagnostic test. The test will be based on protocols-developed by the Centers for Disease Control & Prevention-of an assay for H5N1 virus detection; the virus is available only to laboratories designated by the government's Laboratory Response Network. Celera says its test, which will be validated in collaboration with CDC, will be useful for widespread testing in the case of a flu pandemic. The company will sell the test through its alliance with Abbott.
The power is now in your (nitrile gloved) hands
Sign up for a free account to get more articles. Or choose the ACS option that’s right for you.
Already have an ACS ID? Log in
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on X